Want to see JP:6407 full AI Analyst Report?
6407 Stock Chart & Stats
¥5540.00
-¥76.00(-2.88%)
At close: 4:00 PM EST
¥5540.00
-¥76.00(-2.88%)
Day’s Range― - ―
52-Week Range¥2,361.00 - ¥8,330.00
Previous CloseN/A
Volume278.00K
Average Volume (3M)472.93K
Market Cap
¥402.08B
Enterprise Value¥277.08K
Total Cash (Recent Filing)¥42.84B
Total Debt (Recent Filing)¥34.60B
Price to Earnings (P/E)29.5
Beta1.78
Next Earnings
Aug 10, 2026EPS Estimate
64.97Next Dividend Ex-DateN/A
Dividend Yield1.35%
Share Statistics
EPS (TTM)203.22
Shares Outstanding68,279,450
10 Day Avg. Volume518,100
30 Day Avg. Volume472,929
Financial Highlights & Ratios
PEG Ratio57.49
Price to Book (P/B)1.86
Price to Sales (P/S)1.81
P/FCF Ratio23.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥7,910.00Price Target Upside42.78% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
EPS Forecast (FY)282.27
Revenue Forecast (FY)¥187.25B
Bulls Say, Bears Say
Bulls Say
Profitability MarginsSustained gross margins near 28–29% and EBIT margins in the low-to-mid teens indicate durable product-level profitability and pricing power in industrial components. This margin profile supports reinvestment, withstands cyclical demand swings, and underpins long-term cash generation and resilience.
Conservative LeverageLow debt-to-equity provides balance-sheet flexibility to fund capex, working capital, or acquisitions without heavy interest burden. Conservative leverage reduces refinancing risk across cycles, supporting stable operations and strategic optionality during periods of uneven revenue or investment needs.
Improving Cash GenerationRecent return to positive free cash flow and FCF representing a large share of net income signals improving conversion of earnings to cash. Consistent cash conversion enables internal funding of maintenance capex, aftermarket support, and modest dividends while reducing reliance on external financing over the medium term.
Bears Say
Cash Flow VolatilityIntermittent negative free cash flow and a large 2024 outflow demonstrate volatility in cash generation. Persistent variability complicates planning for capex, R&D, and dividends, increases reliance on short-term funding in down years, and raises execution risk during industry cyclical downturns.
Uneven Revenue TrajectoryAn uneven top-line with a notable 2024 decline indicates sensitivity to customers' capex cycles and end-market demand. This creates forecasting difficulty, pressures margins in weaker periods, and suggests organic growth is not yet consistently robust across product lines or geographies.
Step-up In Absolute DebtWhile leverage ratios remain moderate, the recent increase in total debt versus prior years raises a conditional risk if earnings weaken. Higher absolute debt could constrain capital allocation, increase interest costs, and limit flexibility for strategic investments during cyclical slowdowns.
CKD Corporation News
6407 FAQ
What was CKD Corporation’s price range in the past 12 months?
CKD Corporation lowest stock price was ¥2361.00 and its highest was ¥8330.00 in the past 12 months.
What is CKD Corporation’s market cap?
CKD Corporation’s market cap is ¥402.08B.
When is CKD Corporation’s upcoming earnings report date?
CKD Corporation’s upcoming earnings report date is Aug 10, 2026 which is in 2 days.
How were CKD Corporation’s earnings last quarter?
CKD Corporation released its earnings results on May 15, 2026. The company reported ¥70.95 earnings per share for the quarter, beating the consensus estimate of ¥54.439 by ¥16.511.
Is CKD Corporation overvalued?
According to Wall Street analysts CKD Corporation’s price is currently Undervalued.
Does CKD Corporation pay dividends?
CKD Corporation pays a Semiannually dividend of ¥49 which represents an annual dividend yield of 1.35%. See more information on CKD Corporation dividends here
What is CKD Corporation’s EPS estimate?
CKD Corporation’s EPS estimate is 64.97.
How many shares outstanding does CKD Corporation have?
CKD Corporation has 68,279,450 shares outstanding.
What happened to CKD Corporation’s price movement after its last earnings report?
CKD Corporation reported an EPS of ¥70.95 in its last earnings report, beating expectations of ¥54.439. Following the earnings report the stock price went down -3%.
Which hedge fund is a major shareholder of CKD Corporation?
Currently, no hedge funds are holding shares in JP:6407
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
CKD Corporation
CKD Corporation is a global provider engaged in the design, manufacturing, sale, and export of industrial automation equipment and various components. The company operates through its Automatic Machinery and Component Products segments. Its extensive product range includes sophisticated packaging machines for the medical, pharmaceutical, and food sectors, alongside industrial machinery such as lithium-ion battery winding systems and solder paste inspection devices, as well as lamp-related equipment. CKD also offers labor-saving components like index units, direct drive motors, and pick-and-place units. Additionally, it supplies pneumatic control components, including directional control valves, and drive components such as pneumatic cylinders, auxiliary devices, and hand chucks. The company further provides fine system components and fluid control solutions, which comprise specialized valves and unit systems designed for managing and processing fluids. Established in 1943, the firm was formerly called Chukyo Electric Co., Ltd. until its rebranding to CKD Corporation in July 1979. Its headquarters are situated in Komaki, Japan.
6407 Stock 12 Month Forecast
Average Price Target
¥7,910.00
▲(42.78% Upside)
Technical Analysis
Harmonic Drive Systems
―
Nabtesco
―
THK Co
―
ANEST IWATA Corp.
―
Daihen Corporation
―





